UROTHELIAL CANCER
Clinical trials for UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental bladder cancer drug shows promise but trial halted early
Disease control TerminatedThis study tested an experimental drug called enfortumab vedotin, alone or with other cancer drugs, in people with advanced bladder or urinary tract cancer. The goal was to see if the drug could shrink tumors and control the disease. The trial included 348 participants but was te…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Early trial of experimental cancer combo halted after 21 patients
Disease control TerminatedThis early-stage study tested an experimental oral drug (PF-07265028) alone or combined with an immunotherapy injection (sasanlimab) in 21 people with advanced solid tumors, including stomach, lung, and head/neck cancers. The main goals were to find a safe dose and check for side…
Matched conditions: UROTHELIAL CANCER
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC